Variant report

Variant	rs6905224
Chromosome Location	chr6:38230814-38230815
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:38140845..38143617-chr6:38230207..38231726,2	MCF-7	breast:
2	chr6:38230666..38232627-chr6:38236052..38240073,5	MCF-7	breast:

Extended variants
information (count: 16 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:10)

rs_ID	r²[population]
rs28806180	1.00[EUR][1000 genomes]
rs6901549	1.00[EUR][1000 genomes]
rs6936892	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs73419935	1.00[AMR][1000 genomes]
rs7746501	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs7749028	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs7749143	1.00[EUR][1000 genomes]
rs7754288	1.00[EUR][1000 genomes]
rs9470857	1.00[EUR][1000 genomes]
rs9689341	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1028825	chr6:37495154-38278320	Enhancers Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
2	nsv1021991	chr6:37893949-38738720	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
3	nsv885817	chr6:38036420-39019503	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Strong transcription Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
4	nsv534620	chr6:38049585-38602064	Enhancers Strong transcription Weak transcription Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	9 gene(s)	inside rSNPs	diseases
5	nsv885818	chr6:38147745-38436317	Enhancers Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	inside rSNPs	diseases
6	nsv885820	chr6:38166511-38468887	Weak transcription Enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:97 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:38208200-38236600	Weak transcription	Gastric	stomach
2	chr6:38208200-38255000	Weak transcription	Ovary	ovary
3	chr6:38213400-38232400	Weak transcription	Right Ventricle	heart
4	chr6:38216000-38238000	Weak transcription	Fetal Muscle Trunk	muscle
5	chr6:38218800-38232200	Weak transcription	Small Intestine	intestine
6	chr6:38220000-38238200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
7	chr6:38220600-38241600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
8	chr6:38222000-38234600	Weak transcription	Esophagus	oesophagus
9	chr6:38222600-38232400	Weak transcription	Lung	lung
10	chr6:38223000-38231600	Weak transcription	Fetal Intestine Large	intestine
11	chr6:38223600-38256000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
12	chr6:38224400-38239000	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
13	chr6:38224400-38267600	Weak transcription	Primary T cells from cord blood	blood
14	chr6:38224600-38231800	Weak transcription	Duodenum Mucosa	Duodenum
15	chr6:38224600-38255200	Weak transcription	Primary B cells from cord blood	blood
16	chr6:38224800-38256400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
17	chr6:38225000-38255800	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
18	chr6:38225200-38238600	Weak transcription	Primary T helper cells fromperipheralblood	blood
19	chr6:38225800-38238400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
20	chr6:38225800-38239200	Weak transcription	Primary T helper cells PMA-I stimulated	--
21	chr6:38226400-38258000	Weak transcription	Primary T cells fromperipheralblood	blood
22	chr6:38226600-38256600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
23	chr6:38226600-38257000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
24	chr6:38226800-38231000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr6:38226800-38231000	Enhancers	NHEK	skin
26	chr6:38227000-38231800	Enhancers	HMEC	breast
27	chr6:38227400-38231200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr6:38228800-38232800	Enhancers	iPS-18 Cell Line	embryonic stem cell
29	chr6:38228800-38233000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
30	chr6:38229000-38233000	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr6:38229000-38233200	Enhancers	Brain Substantia Nigra	brain
32	chr6:38229200-38231000	Enhancers	HUES6 Cell Line	embryonic stem cell
33	chr6:38229400-38231000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr6:38229400-38231000	Enhancers	iPS-15b Cell Line	embryonic stem cell
35	chr6:38229400-38231000	Enhancers	Hela-S3	cervix
36	chr6:38229400-38231200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr6:38229400-38231400	Enhancers	Fetal Muscle Leg	muscle
38	chr6:38229400-38232800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr6:38229400-38233000	Enhancers	Brain Angular Gyrus	brain
40	chr6:38229400-38233000	Enhancers	Brain Hippocampus Middle	brain
41	chr6:38229400-38233400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
42	chr6:38229400-38233600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
43	chr6:38229600-38231000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr6:38229600-38231000	Enhancers	Brain Germinal Matrix	brain
45	chr6:38229600-38231200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
46	chr6:38229800-38231200	Weak transcription	Fetal Intestine Small	intestine
47	chr6:38229800-38231600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
48	chr6:38229800-38231800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr6:38230000-38231200	Enhancers	HUVEC	blood vessel
50	chr6:38230200-38231000	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links